About 3 results found for searched term "CL075" (0.565 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M29713 | CL075 | TLR |
| 3M002 | ||
| CL075 (3M002) is a selective TLR8 agonist with immunomodulating properties. CL075 triggers a MyD88-dependent signaling pathway to elicit production of inflammatory cytokines and type I interferons (IFNs) via activation of NF-κB and IRF7, respectively. | ||
| M15029 | Recombinant Mouse CT-1 (HEK 293) | Cytokines and Growth Factors |
| CTF1; CT-1 | ||
| Cardiac trophin-1 (CT-1) is a member of the cytokine family, which also includes IL-6, IL-11, leukemia suppressor (LIF), tumor suppressor M (OSM), and ciliary neurotrophin (CNTF). Protein structure: CT-1 (SER2-ALA203), Accession # Q60753-1. | ||
| M25003 | Talquetamab | Others |
| JNJ-64407564 | ||
| Talquetamab (JNJ-64407564) is a potentially first-in-class humanized IgG4ҡ/λ bispecific antibody that binds to GPRC5D (G-protein-coupled receptor family, group C5, member D) and CD3, and induces T-cell-mediated by T-cell recruitment and activation. killing of GPRC5-expressing MM cells through T cell recruitment and activation.Talquetamab (JNJ-64407564) has antitumor activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
